temozolomide has been researched along with Leukemia, Plasma Cell in 1 studies
Leukemia, Plasma Cell: A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhai, Y | 1 |
| Shang, J | 1 |
| Yao, W | 1 |
| Wu, D | 1 |
| Fu, C | 1 |
| Yan, L | 1 |
1 other study available for temozolomide and Leukemia, Plasma Cell
| Article | Year |
|---|---|
Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.
Topics: Antineoplastic Agents, Alkylating; Central Nervous System; Central Nervous System Neoplasms; Dacarba | 2022 |